Jacob Chacko, PRESIDENT AND CEO at Oric Pharmaceuticals, Inc. (ORIC), sold 66,748 shares at $9.06 ($605K) on 2025-12-16, disclosed to the SEC on 2025-12-17.
Seasonal sale ($605k) by PRESIDENT AND CEO — this insider has traded ORIC in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.06 | 33,374 | $302K | 50.0% |
| 2 | $9.06 | 33,374 | $302K | 50.0% |
| Total | $9.06 avg | 66,748 | $605K | 100% |
| Filing → |
| ORIC | SELL | 2025-09-24 | $1.4M | — | Filing → |
| ORIC | SELL | 2024-12-17 | $408K | — | Filing → |
| ORIC | SELL | 2024-03-08 | $648K | — | Filing → |